Variant report
Variant | esv994443 |
---|---|
Chromosome Location | chr20:1385239-1392933 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:8)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr20:1384990..1387871-chr20:1389849..1391425,2 | K562 | blood: | |
2 | chr20:1388186..1390453-chr20:1399929..1402694,2 | K562 | blood: | |
3 | chr20:1387186..1389098-chr20:1391471..1393677,2 | MCF-7 | breast: | |
4 | chr20:1391237..1393735-chr20:1396844..1398411,3 | K562 | blood: | |
5 | chr20:1384990..1387871-chr20:1389849..1391425,2 | K562 | blood: | |
6 | chr20:1374791..1377395-chr20:1388884..1390483,2 | K562 | blood: | |
7 | chr20:1389651..1392477-chr20:1392965..1396440,4 | K562 | blood: | |
8 | chr20:1387186..1389098-chr20:1391471..1393677,2 | MCF-7 | breast: |
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-FKBP1A-3 | chr20:1385809-1385927 | NONHSAT078110 |
2 | lnc-FKBP1A-3 | chr20:1385809-1385927 | NONHSAT078111 |
3 | lnc-FKBP1A-3 | chr20:1389013-1389091 | NONHSAT078110 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs367589868 | chr20:1385302-1385303 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs56377442 | chr20:1385325-1385326 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs370821157 | chr20:1385381-1385382 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs374909209 | chr20:1385382-1385383 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs75690265 | chr20:1385386-1385387 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs56129657 | chr20:1385400-1385401 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs6042026 | chr20:1385417-1385418 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs35960376 | chr20:1385435-1385436 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs541240411 | chr20:1385449-1385450 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs368830787 | chr20:1385459-1385460 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs564270614 | chr20:1385471-1385472 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs533239351 | chr20:1385545-1385546 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs543454621 | chr20:1385573-1385574 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs138996754 | chr20:1385618-1385619 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs185347855 | chr20:1385628-1385629 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs529226666 | chr20:1385674-1385675 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs549270339 | chr20:1385705-1385706 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs565802351 | chr20:1385737-1385738 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs372108185 | chr20:1385787-1385788 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs6109816 | chr20:1385863-1385864 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs528316533 | chr20:1385865-1385866 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs369814799 | chr20:1385866-1385867 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs551585076 | chr20:1385898-1385899 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs368140457 | chr20:1385997-1385998 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs115072765 | chr20:1386019-1386020 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs537138876 | chr20:1386037-1386038 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs71328071 | chr20:1386053-1386054 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
28 | rs567260099 | chr20:1386062-1386063 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs190885766 | chr20:1386064-1386065 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs73081790 | chr20:1386065-1386066 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs181978154 | chr20:1386092-1386093 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs187579063 | chr20:1386094-1386095 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs541265264 | chr20:1386183-1386184 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs557924436 | chr20:1386197-1386198 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs111361508 | chr20:1386223-1386224 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs6105076 | chr20:1386242-1386243 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs191508135 | chr20:1386278-1386279 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs147213726 | chr20:1386290-1386291 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs6042032 | chr20:1386295-1386296 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs542069228 | chr20:1386329-1386330 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs183827978 | chr20:1386335-1386336 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs551648811 | chr20:1386343-1386344 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs202013848 | chr20:1386383-1386384 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs200465316 | chr20:1386385-1386386 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs6105077 | chr20:1386395-1386396 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs530681400 | chr20:1386424-1386425 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs117780492 | chr20:1386441-1386442 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs567219733 | chr20:1386470-1386471 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs1474879 | chr20:1386473-1386474 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
50 | rs552680220 | chr20:1386499-1386500 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Hodgkin''s lymphoma | 18641027 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17603634 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autism | 18414403 | CNVD |
Neurocytoma | 17123091 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16397240 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Wilms tumour | 21544195 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 16272173 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 19627613 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastric cancer | 17908304 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Oral cancer | 21386901 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Colorectal cancer | 21645411 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 17363583 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:1380600-1388400 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
2 | chr20:1382400-1386000 | Weak transcription | Rectal Mucosa Donor 29 | rectum |
3 | chr20:1382400-1388400 | Weak transcription | Placenta | Placenta |
4 | chr20:1383200-1388000 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
5 | chr20:1383600-1385600 | Weak transcription | Fetal Intestine Large | intestine |
6 | chr20:1383800-1396000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
7 | chr20:1384400-1395600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
8 | chr20:1384400-1396000 | Weak transcription | HMEC | breast |
9 | chr20:1385600-1387800 | Enhancers | Fetal Intestine Large | intestine |
10 | chr20:1385800-1387600 | Enhancers | Fetal Intestine Small | intestine |
11 | chr20:1386200-1386400 | Enhancers | Rectal Mucosa Donor 29 | rectum |
12 | chr20:1388400-1389000 | Strong transcription | Skeletal Muscle Female | skeletal muscle |
13 | chr20:1388400-1389200 | Enhancers | Placenta | Placenta |
14 | chr20:1389000-1396800 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
15 | chr20:1389200-1396400 | Weak transcription | Placenta | Placenta |
16 | chr20:1390200-1390600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
17 | chr20:1390600-1396600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |